Search Results
Feb 12, 2026, 08:36 ET Prime Insurance Announces Strategic Addition of Fernando "Fernie" Alvarez to Support High Net Worth & Excess & Surplus Lines Growth
market knowledge and a collaborative approach that aligns well with how we continue to evolve our High Net Worth and specialty programs," said Rick J. Lindsey, Chairman & CEO of Prime Insurance. "His experience across real estate, construction, and sports-related risks adds valuable perspective
More news about: Prime Insurance Company
Feb 12, 2026, 08:30 ET FLAGSTAR BANK, N.A. DECLARES QUARTERLY CASH DIVIDENDS ON ITS COMMON STOCK AND PREFERRED STOCKS
upper Midwest, along with a significant presence in fast-growing markets in Florida and the West Coast.Investor Contact: Salvatore J. DiMartino(516) 683-4286
More news about: Flagstar Bank, N.A.
Feb 12, 2026, 08:05 ET INOVIO to Participate in Upcoming Scientific and Investor Conferences
https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/j7XuLLN6VFvrBMcQmqB55w Available abstracts will be shared on INOVIO's website following presentations. Replay of the investor
More news about: INOVIO Pharmaceuticals, Inc.
Feb 12, 2026, 08:00 ET ETS Research Institute Awarded $4 Million U.S. Department of Education Grant to Advance AI-Enhanced Learning in Higher Education
of Postsecondary Education (FIPSE) to reimagine how artificial intelligence can support learning in higher education. The initiative (Award No. P116J250806) is part of the
More news about: ETS
Feb 12, 2026, 08:00 ET Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology
program and chief of musculoskeletal oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). "This multi-institutional national post-market surveillance study will help define the future of how we can
More news about: ONKOS SURGICAL
Feb 12, 2026, 07:30 ET Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
9. Mirza MR, et al. N Engl J Med. 2023; 388:2145-2158. 10. Eskander RN, et al. N Eng J Med. 2023;388:2159-2170.
More news about: Karyopharm Therapeutics Inc.
Feb 12, 2026, 07:30 ET Soligenix Details Recent Progress and Upcoming Milestones
treat rare diseases where there is an unmet medical need, today issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber. The content of this letter is provided below.
More news about: SOLIGENIX, INC.
Feb 12, 2026, 07:00 ET USAP Texas Antitrust Lawsuit Advances: Plaintiffs Expand Class Statewide and to ASCs
and Michael Davis of Gibbs & Bruns LLP; Kellie Lerner, Keagan Potts, and Harrison McAvoy of Shinder Cantor Lerner LLP; Kimberly A. Justice, Robert J. Wozniak, and Samantha M. Gupta of Freed Kanner London & Millen LLP; and Justin S. Nematzadeh of Nematzadeh PLLC.ABOUT GIBBS
More news about: Gibbs & Bruns LLP
Feb 12, 2026, 07:00 ET Howmet Aerospace Reports Fourth Quarter and Full Year 2025 Results
meet increased demand, production targets or commitments; (i) competition from new product offerings, disruptive technologies or other developments; (j) geopolitical, economic, and regulatory risks relating to Howmet Aerospace's global operations, including geopolitical and diplomatic tensions, instabilities,
More news about: Howmet Aerospace Inc.
Feb 12, 2026, 06:57 ET AEP Reports Fourth Quarter and Full-Year 2025 Results, Reaffirms Long-Term Growth Outlook
SEC Matter Loss Contingency(j)—
More news about: American Electric Power
Feb 12, 2026, 06:30 ET Entergy reports 2025 financial results, initiates 2026 guidance
(0.10)(j)(0.01)
More news about: Entergy Corporation
Feb 12, 2026, 06:00 ET Clayco Supports Deep Atomic Consortium with Department of Energy Submissions for Proposed First Nuclear-Powered AI Data Center Campus in U.S.
nuclear power solutions that meet the performance, reliability and sustainability needs of next-generation computing infrastructure," said William G. J. Theron, founder and CEO of Deep Atomic. "Working with Clayco and our consortium partners, we're proud to present a proposal to the DOE that pairs practical
More news about: Clayco
Feb 12, 2026, 04:30 ET Jacobs and PA Consulting-led Consortium Supports United Kingdom Transport Security
Jacobs (NYSE: J), in strategic partnership with
More news about: Jacobs
Feb 12, 2026, 03:14 ET NX Taiwan啟用臺南NEXT11倉庫作為新物流樞紐
https://drive.google.com/file/d/1J1Ex5NUATQlhevou5C8q1JFfIRaSVEED/view?usp=drive_link NX Taiwan將這一新的物流樞紐設立於臺灣最大食品與流通企業集團統一企業集團(Uni-President Enterprises Group)所開發的臺南新市物流園區內。該園區交通便利，可快速
More news about: NIPPON EXPRESS HOLDINGS, INC.
Feb 12, 2026, 02:10 ET Kiteskraft unveils their latest publication, The Power List to announce the mentors and change-makers that are shaping progress in India
a distinguished leader known for academic excellence, professional achievement, and deep commitment to community empowerment. Inspired by his father, J. Bheeman, a National Teacher's Awardee, he imbibed strong values of integrity, education, and perseverance early in life. He holds a B.Sc. in Computer
More news about: Kiteskraft Productions LLP
Feb 12, 2026, 02:01 ET J INTS BIO Reports Fourth-Generation EGFR Inhibitor JIN-A02 in Clinical Cancer Research
SEOUL, South Korea, Feb. 12, 2026 /PRNewswire/ -- J INTS BIO, Inc. announced that research findings on its investigational fourth-generation EGFR tyrosine kinase inhibitor (TKI), JIN-A02, have been published in Clinical Cancer
More news about: J INTS BIO
Feb 12, 2026, 02:00 ET Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System
contrast-induced nephropathy. Am J Cardiol 113 (1): 49-53.2 Call J, Sacrinty M, Applegate R, Little W, Santos R et al. (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol 18 (10):
More news about: Bracco Group
Feb 12, 2026, 02:00 ET Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System
contrast-induced nephropathy. Am J Cardiol 113 (1): 49-53.2 Call J, Sacrinty M, Applegate R, Little W, Santos R et al. (2006) Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy. J Invasive Cardiol 18 (10):
More news about: Bracco Group
Feb 11, 2026, 22:46 ET Immutable Announces Launch of Mintory Web3 Game Economy Community and Onboarding of "Ragnarok Sharing Hero NFT"
https://discord.com/invite/j5vwjVK3jC
More news about: Immutable
Feb 11, 2026, 17:31 ET EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
EGFR-NSCLC companies developing emerging therapies, such as ArriVent BioPharma (NASDAQ: AVBP), Akeso Biopharma (HKG: 9926), Summit Therapeutics (NASDAQ: SMMT), J INTS BIO, Merus (NASDAQ: MRUS), Merck (NYSE: MRK), Kelun-Biotech (HKG: 6990), Genprex (NASDAQ: GNPX), Cullinan Oncology (NASDAQ: CGEM), Taiho Pharma,
More news about: DelveInsight Business Research, LLP
Feb 11, 2026, 17:01 ET Sun Life Reports Fourth Quarter and Full Year 2025 Results
Innovative capital instruments consist of Sun Life ExchangEable Capital Securities ("SLEECS"), see section J - Capital and Liquidity Management in the 2025 Annual MD&A.
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 17:01 ET Sun Life Reports Fourth Quarter and Full Year 2025 Results
Innovative capital instruments consist of Sun Life ExchangEable Capital Securities ("SLEECS"), see section J - Capital and Liquidity Management in the 2025 Annual MD&A.
More news about: Sun Life Financial Inc. - Financial News
Feb 11, 2026, 16:33 ET Western Copper and Gold Announces C$50 Million Bought Deal Financing
Prospectus and the Registration Statement may be obtained, for free upon request, from Stifel Canada at 161 Bay Street, Suite 3800, Toronto, Ontario, Canada M5J 2S1 or by email at [email protected] Offering is scheduled
More news about: Western Copper and Gold Corporation
Feb 11, 2026, 16:30 ET Ameren Announces 2025 Results, Affirms Guidance for 2026 Earnings and Issues Long-Term Growth Guidance
weighted-average basic common shares outstanding in 2025."Our steadfast focus remains on the customers and communities we serve," said Martin J. Lyons Jr., chairman, president and chief executive officer of Ameren Corporation. "Customers depend on us to bring them reliable, resilient energy while
More news about: Ameren Corporation
Feb 11, 2026, 16:12 ET Bitcoin Price Drop Sends Mining Hardware Prices to Historic Lows as Hashprice Hits New Bottom
understate the depth of hardware discount occurring in specific market segments. While $15 per terahash represents an average "naked price" for sub-19 J/TH machines, fully deployed, ready-to-hash units
More news about: Compass Mining